Clinical trials
Prostatic Hyperplasia trials in China with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 2 |
| 2010 | 1 |
| 2013 | 1 |
| 2017 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 3 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Not yet recruiting | 7 |
| Recruiting | 6 |
| Unknown status | 6 |
| Terminated | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hospital Authority, Hong Kong | 4 |
| Chinese PLA General Hospital | 3 |
| Fuzhou General Hospital | 2 |
| Qing Yuan | 2 |
| Shanghai East Hospital | 2 |
| First Affiliated Hospital of Guangxi Medical University | 1 |
| First Affiliated Hospital of Zhejiang University | 1 |
| First Affiliated Hospital, Sun Yat-Sen University | 1 |
| Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 1 |
| Medtecx Co Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Hyperplasia | 29 |
| Lower Urinary Tract Symptoms | 7 |
| Urinary Retention | 3 |
| Acute Disease | 1 |
| Cholecystitis | 1 |
| Coronary Artery Disease | 1 |
| Erectile Dysfunction | 1 |
| Femur Head Necrosis | 1 |
| Kidney Calculi | 1 |
| Osteoarthritis, Knee | 1 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.